BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 19482216)

  • 1. Glucocorticoid resistance in inflammatory diseases.
    Barnes PJ; Adcock IM
    Lancet; 2009 May; 373(9678):1905-17. PubMed ID: 19482216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    J Allergy Clin Immunol; 2013 Mar; 131(3):636-45. PubMed ID: 23360759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticosteroids.
    Barnes PJ
    Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.
    Barnes PJ; Ito K; Adcock IM
    Lancet; 2004 Feb; 363(9410):731-3. PubMed ID: 15001333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and resistance in glucocorticoid control of inflammation.
    Barnes PJ
    J Steroid Biochem Mol Biol; 2010 May; 120(2-3):76-85. PubMed ID: 20188830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
    Barnes PJ
    Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies for chronic obstructive pulmonary disease.
    Barnes PJ
    Med Princ Pract; 2010; 19(5):330-8. PubMed ID: 20639653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase-2 and airway disease.
    Barnes PJ
    Ther Adv Respir Dis; 2009 Oct; 3(5):235-43. PubMed ID: 19812111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response.
    Adcock IM; Cosio B; Tsaprouni L; Barnes PJ; Ito K
    Antioxid Redox Signal; 2005; 7(1-2):144-52. PubMed ID: 15650403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness.
    Bantel H; Schmitz ML; Raible A; Gregor M; Schulze-Osthoff K
    FASEB J; 2002 Nov; 16(13):1832-4. PubMed ID: 12223450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid resistance in airway disease.
    Barnes PJ
    Proc Am Thorac Soc; 2004; 1(3):264-8. PubMed ID: 16113444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy.
    Adcock IM; Ito K
    Proc Am Thorac Soc; 2005; 2(4):313-9; discussion 340-1. PubMed ID: 16267355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease.
    To Y; Ito K; Kizawa Y; Failla M; Ito M; Kusama T; Elliott WM; Hogg JC; Adcock IM; Barnes PJ
    Am J Respir Crit Care Med; 2010 Oct; 182(7):897-904. PubMed ID: 20224070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid effects on cell signalling.
    Barnes PJ
    Eur Respir J; 2006 Feb; 27(2):413-26. PubMed ID: 16452600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression.
    Ito K; Yamamura S; Essilfie-Quaye S; Cosio B; Ito M; Barnes PJ; Adcock IM
    J Exp Med; 2006 Jan; 203(1):7-13. PubMed ID: 16380507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin.
    Biswas S; Rahman I
    Mol Nutr Food Res; 2008 Sep; 52(9):987-94. PubMed ID: 18327875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-regulated transcription factors.
    Adcock IM
    Pulm Pharmacol Ther; 2001; 14(3):211-9. PubMed ID: 11448148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.